Intravenous immune globulin(Peking University People's Hospital)

N/A

Report date: 2022/12/05 20:00:54

Base Information

Drug NameIntravenous immune globulin(Peking University People's Hospital)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunoglobulin replacements
TargetsImmunoglobulin
Therapy Area/IndicationsParturitionPurpura, Thrombocytopenic, Idiopathic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParturitionPurpura, Thrombocytopenic, Idiopathic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A